Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

nd strong inhibitors or inducers of CYP3A4 should be avoided as they may affect serum concentration of Tasigna.

Concomitant strong CYP3A4 inhibitors

The concomitant use of strong CYP3A4 inhibitors or anti-arrhythmic drugs (including, but not limited to amiodarone, disopyramide, procainamide, quinidine, and sotalol) and other drugs that may prolong QT interval (including, but not limited to chloroquine, halofantrine, clarithromycin, haloperidol, methadone, moxifloxacin, bepridil, and pimozide) should be avoided. Should treatment with any of these agents be required, it is recommended that therapy with Tasigna be interrupted. If interruption of treatment with Tasigna is not possible, patients who require treatment with a drug that prolongs QT or strongly inhibits CYP3A4 should be closely monitored for prolongation of the QT interval, and a dose reduction to 1/2 the daily dose is recommended (400 mg once daily). If the strong inhibitor is discontinued, a washout period should be allowed before Tasigna is adjusted upward to the indicated dose. Close monitoring for prolongation of the QT interval is indicated for patients who cannot avoid strong CYP3A4 inhibitors. Grapefruit products and other foods that are known to inhibit CYP3A4 should also be avoided.

Concomitant strong CYP3A4 inducers

The concomitant use of strong CYP3A4 inducers should be avoided (including, but not limited to, dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital). Patients should also refrain from taking St John's Wort. If patients must be co-administered a strong CYP3A4 inducer, the dose of Tasigna may need to be increased, depending on patient tolerability. If the strong inducer is discontinued, the Tasigna dose should be reduced to the indicated Tasigna dose. Tasigna is a competitive inhibitor of CYP3A4, CYP2C8, CYP2C9, CYP2D6, and UGT1A1. In vitro studies also suggest that nilotinib may i
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... DIEGO , May 20, 2013  Volcano Corporation ... manufacturer of precision guided therapy tools designed to enhance ... disease, today announced it will highlight its efforts to ... its Fractional Flow Reserve (FFR) and iFR ® ... and educational presentations and events at EuroPCR 2013 in ...
(Date:5/20/2013)... , May 20, 2013 The Board ... subsidiary companies include OMNIlife science®, Inc., Enztec, Ltd., and ... their Board.  Guy Mayer , ... Chairman of the Board of Directors and David Johnson, ... a director. Before joining OSI as ...
(Date:5/20/2013)... , May 20, 2013  Upsher-Smith Laboratories, ... development of new treatments for diseases of the ... its newly designed website, upsher-smith.com . The ... narratives.  As part of the company,s mission statement ... branding campaign centers around people with a story ...
Breaking Medicine Technology:Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Upsher-Smith Introduces Newly Redesigned Corporate Website 2
... , WALTHAM, Mass., Dec. ... research and advisory firms for pharmaceutical and healthcare issues, ... metastatic colorectal cancer treatment, Roche/Chugai,s Avastin will face increasing ... France and Spain. , The new Special European Physician ...
... Genoptix, Inc. (Nasdaq: GXDX ), a specialized laboratory ... Bank 2009 MedTools Investor Conference to be held at the ... , Genoptix,s EVP and COO, Sam Riccitelli, will be ... 2009. He will provide an overview of the Company,s ...
Cached Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center,     Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... Heritage Woods of Gurnee , a BMA ... hosting Breakfast and Bingo at 8:30 a.m. on Friday, ... 3775 Grand Ave. in Gurnee, Illinois, serves older adults ... some help to maintain their independence. , "Come and ... says Tammy Temaner-Rosas, Director of Marketing for Heritage Woods ...
(Date:5/20/2013)... May 20, 2013 When people ... not always to become a celebrity. New Jersey ... 2013 ABC News report (“Chris Christie Says Lap ... clear that the surgery was not done so ... gain celebrity status as a former lap band ...
(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Combat Skin Cancer In Summer Months 2
... , SAN FRANCISCO, Dec. 16 ... software and professional services solutions for the healthcare industry, ... division. Quantros has named software industry veteran Michael Tulloch, ... work from the company,s new Marlborough, MA office. , ...
... Boston University School of Medicine,s (BUSM) Pulmonary Center has ... Heart, Lung, and Blood Institute to derive stem cells ... Darrell Kotton, MD, associate professor of medicine and ... medicine, are the principal investigators of this new grant ...
... A ... impact on employee presenteeism and bottom line benefits. , ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... employee participation in health and wellness programs by implementing an incentive program. ...
... Two million screenings conducted through national AAD program ... from melanoma, the deadliest form of skin cancer, almost every ... That,s why thousands of dermatologists across the country offer free ... of Dermatology,s (AAD) National Melanoma/Skin Cancer Screening Program. The program ...
... ... the world,s largest online community for physicians, today announced the ... MD Social Media Conversations ." The report examines physician ... complete analysis of a variety of topics, including the therapies ...
... , , WILMINGTON, Delaware, December ... to outsource their accurate forecast models,for new and inmarket ... solutions to various players. These pharma,forecasting solutions are designed ... These have a substantial impact on pricing, launch, product ...
Cached Medicine News:Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3
... membrane parasite soluble lysate ... as antigen. Since this ... than the recombinant kit, ... use two ELISA techniques ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
... The dual-electrode SPL defibrillator lead ... design, offering the flexibility and ... Designed for the physician who ... shocking coils, the SPL lead ...
... The Medtronic Subcutaneous Lead ... implanted subcutaneously with the use ... Model 6996T. Improved SQ design ... DFTs, a fast and easy ...
Medicine Products: